학술논문
Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan
Document Type
Article
Author
Source
In Journal of Microbiology, Immunology and Infection August 2021 54(4):588-595
Subject
Language
ISSN
1684-1182